A detailed history of Bank Of America Corp transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 57 shares of NERV stock, worth $128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57
Previous 169 66.27%
Holding current value
$128
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.55 - $3.4 $285 - $380
-112 Reduced 66.27%
57 $0
Q2 2024

Aug 14, 2024

BUY
$2.33 - $3.65 $102 - $160
44 Added 35.2%
169 $0
Q1 2024

May 15, 2024

SELL
$2.5 - $12.47 $7 - $37
-3 Reduced 2.34%
125 $0
Q4 2023

Feb 14, 2024

BUY
$3.96 - $7.85 $506 - $1,004
128 New
128 $0
Q4 2022

Feb 10, 2023

BUY
$1.43 - $13.43 $8 - $80
6 New
6 $0

Others Institutions Holding NERV

About Minerva Neurosciences, Inc.


  • Ticker NERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,340,190
  • Market Cap $12.1M
  • Description
  • Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...
More about NERV
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.